Sotera Health reaffirms FY24 adjusted EPS view 67c-75c, consensus 72c

Sotera Health (SHC) is reaffirming the following 2024 outlook ranges previously provided: Net revenues and Adjusted EBITDA growth in the range of 4.0% to 6.0%, Interest Expense in the range of $165 million to $175 million, Tax rate applicable to Adjusted Net Income in the range of 31.5% to 34.5%, Adjusted EPS in the range of $0.67 to $0.75, A weighted-average fully diluted share count in the range of 283 million to 285 million shares, and The following range in the 2024 outlook is being updated: Capital expenditures are now expected to be in the range of $175 million to $185 million, from previous guidance of $205 million to $225 million.